Top Adjuster Attacks on Pharmacy Liens — And How to Rebut Them

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | August 2, 2024 | 9 min read

Insurance adjusters and defense attorneys use a predictable set of attacks to challenge pharmacy liens in personal injury settlements. Here are the five most common attacks — and the clinical, legal, and evidentiary responses that neutralize each one.

Top Adjuster Attacks on Pharmacy Liens — And How to Rebut Them

Insurance adjusters and defense attorneys have developed a predictable set of arguments against pharmacy liens in personal injury cases. Understanding these attacks — and the responses — allows PI attorneys to anticipate challenges, prepare documentation proactively, and protect pharmacy lien balances in settlement negotiations.

[!KEY] The five standard adjuster attacks on pharmacy liens — insurance availability, causation, brand pricing, over-treatment, and unreasonable charges — all have established clinical, legal, and evidentiary responses, but each requires preparation that should begin at case enrollment, not at settlement negotiations.

Attack #1: "Why Isn't the Patient Using Their Health Insurance?"

The Attack: The patient has health insurance. Why should the pharmacy lien — paid from settlement — cover medications instead of regular insurance? The defense argues the lien balance is inflated because the patient should have used insurance.

The Rebuttal:

Several legitimate reasons prevent using health insurance for accident-related prescriptions:

Coverage denials. Health insurers routinely deny claims for accident-related care under "other coverage available" clauses when there is pending liability coverage. The insurer may require the liability carrier to pay first, creating a catch-22 where neither pays while the case is pending.

Subrogation complexity. Health insurers typically assert subrogation rights against accident recoveries. Using health insurance creates a parallel subrogation interest that must be satisfied at settlement, often reducing net recovery for the patient. A pharmacy lien — part of the overall damages narrative — can produce a higher net recovery than using health insurance and triggering subrogation.

Formulary limitations. Health insurance formularies frequently do not cover brand-name medications that are clinically appropriate. A physician who prescribes Qulipta for post-traumatic migraine may find it not covered by the patient's insurance, even though it is the medically appropriate choice.

Out-of-pocket affordability. Even with insurance, co-pays, deductibles, and prior authorization delays create access barriers for accident victims who are often missing work and facing financial hardship.

The pharmacy lien is not a workaround — it is an appropriate mechanism for ensuring that accident victims receive clinically appropriate care regardless of insurance status.

Attack #2: "The Medications Are Not Related to the Accident"

The Attack: The patient had pre-existing conditions. Some of these medications were prescribed for pre-existing problems. Why is the accident responsible for the pharmacy lien?

The Rebuttal:

The pre-existing condition argument requires the defense to prove that each contested medication was prescribed for a pre-existing condition — not for the accident injuries. This is a factual question that the defense must establish with evidence, not simply assert.

The eggshell plaintiff doctrine. Under the eggshell plaintiff rule, a defendant takes the plaintiff as they find them. An accident that aggravates a pre-existing condition, or that triggers a latent condition (such as fibromyalgia or post-traumatic migraine in someone with a predisposition), is still fully liable for the resulting harm.

New prescriptions after the accident are facially related. A prescription for gabapentin that begins the week after an accident and corresponds to documented herniated disc pathology is presumptively related to the accident. The defense must affirmatively demonstrate it relates to a pre-existing condition.

MERIT documentation. LienScripts' MERIT documentation addresses causation directly — our pharmacy documentation explicitly ties each prescription to the documented accident-related diagnoses in the treating physicians' records.

Attack #3: "Brand-Name Medications Are Unnecessary — Only Generic Prices Are Legitimate"

The Attack: The patient was prescribed Celebrex instead of generic celecoxib, Qulipta instead of topiramate, Skelaxin instead of generic metaxalone. The adjuster argues that only generic-equivalent pricing is reasonable.

The Rebuttal:

This argument assumes that brand and generic drugs are clinically interchangeable. They often are — but not always, and the prescribing physician decides, not the adjuster.

Clinical non-interchangeability. Some brand medications are not simply more expensive generics — they represent distinct formulations, mechanisms, or pharmacokinetic profiles. Qulipta is a CGRP receptor antagonist that does not have a generic equivalent and works through a mechanism that topiramate does not share. Journavx (suzetrigine) is a Nav1.8 inhibitor with no generic equivalent and no pharmacological equivalent. These are not "brand vs. generic" situations — they are different drug classes.

The prescribing physician decides. When a licensed physician prescribes a brand drug, they are exercising clinical judgment. Challenging that judgment requires a competing clinical opinion — not simply an adjuster's assumption that cheaper equals appropriate.

Bioequivalence windows. For true brand-generic pairs, the FDA's bioequivalence standard allows generics to have between 80% and 125% of the brand's bioavailability. For some patients and conditions, this window creates clinically meaningful differences in drug levels.

The prescribing choice documents injury severity. A physician who selects Journavx for acute pain — rather than defaulting to generic opioids — is documenting that the patient's pain severity warrants the newest non-opioid analgesic. This prescription choice itself is evidence of injury severity.

[!KEY] When an adjuster challenges brand-name medication pricing, request a written opinion from the prescribing physician explaining why the brand was selected over a generic — this converts a negotiating tactic into a formal clinical dispute that requires a competing medical opinion to sustain.

Attack #4: "The Patient Had Too Many Medications — This Is Over-Treatment"

The Attack: A patient on six medications is being over-treated, and the pharmacy lien is padded. The defense argues that the number of prescriptions reflects billing maximization rather than clinical necessity.

The Rebuttal:

This argument misunderstands how multi-system injury is treated. See our full discussion in Myth: Multiple Prescriptions Mean Over-Treatment, but the core response is:

Personal injury accidents injure multiple biological systems simultaneously. Muscle spasm, inflammation, neuropathic pain, post-traumatic migraine, sleep disruption, and GI protection each require drugs working through completely different mechanisms. There is no single medication that addresses all of these systems. A patient with five injury components appropriately takes five medications.

Attack #5: "The Pharmacy Prices Are Unreasonable"

The Attack: The drugs on the lien cost more than what insurance would have paid. The defense argues the pharmacy lien represents inflated billing that should be reduced to "reasonable" market rates.

The Rebuttal:

The question of what constitutes reasonable pricing for medical services is a legal and factual question — not one that adjusters determine unilaterally.

Risk-adjusted pricing. A pharmacy lien assumes the risk that the case may not resolve and payment may never come. This risk is factored into lien-based pricing in the same way that any risk-compensated service is priced. Attorneys take contingency fees — at a higher effective hourly rate than flat fee work — precisely because contingency compensation must reflect the risk of non-payment.

Reasonable value is not insurance rate. The measure of reasonable value for medical services in PI cases is not what a health insurer would pay — it is the reasonable value of the service in the relevant market. Pharmacy lien pricing reflects the risk-adjusted reasonable value of prescription dispensing in the PI pharmacy market.

[!KEY] Adjusters who argue that pharmacy lien pricing should be reduced to insurance reimbursement rates are conflating two legally distinct standards — insurance contract rates are a product of network negotiation, while the reasonable value standard in PI cases is based on the market value of the service, which is a jury question, not an adjuster determination.

[!TIP] MERIT documentation addresses all five adjuster attacks in a single document — medical necessity language for each medication, tied to accident-related diagnoses, with a pharmacist signature — making it the most efficient single piece of preparation for settlement negotiations.

Proactive Documentation: The Best Defense Against All Five Attacks

The most effective response to adjuster attacks is proactive documentation that prevents the attacks from gaining traction in the first place:

1. MERIT documentation — medical necessity language for each medication, tied to accident-related diagnoses
2. Complete medical records — prescription records with corresponding physician visit notes documenting clinical assessment at each prescription date
3. Causation timeline — showing that each prescription began after the accident date and corresponds to the accident-related diagnoses
4. Treating physician support — letters or declarations from treating physicians supporting the clinical necessity of the prescribed medications

LienScripts provides MERIT documentation as a standard component of our pharmacy lien service. This documentation is specifically designed to anticipate and rebut the standard adjuster attacks.

Contact LienScripts to discuss how MERIT documentation protects pharmacy liens in your cases.

Related Resources

• Myth: Multiple Prescriptions Mean Over-Treatment
• How to Use Pharmacy Records in Your Demand Package
• Why PI Patients Often Need Multiple Medications
• Pharmacy Services for Personal Injury Clients: How It Works
• What Are Medication Liens?